[1]
Zhihao Zhang, Wei Hou, Shuliang Chen, 2022: Updates on CRISPR-based gene editing in HIV-1/AIDS therapy, Virologica Sinica, 37, 1-10. doi: 10.1016/j.virs.2022.01.017
[2]
Zhanqi Dong, Qi Qin, Zhigang Hu, Peng Chen, Liang Huang, Xinling Zhang, Ting Tian, Cheng Lu, Minhui Pan, 2019: Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms, Virologica Sinica, 34, 444-453. doi: 10.1007/s12250-019-00121-4
[3]
Cheng Peng, Mengji Lu, Dongliang Yang, 2015: CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV, Virologica Sinica, 30, 317-325. doi: 10.1007/s12250-015-3660-x
[4]
Zhipin Liang, Zhiyuan Guo, Xin Wang, Xiaohong Kong, Chang Liu, 2012: Two Retroviruses Packaged in One Cell Line can Combined Inhibit the Replication of HIV-1 in TZM-bl Cells ^*, Virologica Sinica, 27, 339-344. doi: 10.1007/s12250-012-3263-8
[5]
卢曾军, 曹轶梅, 刘在新*, 谢庆阁, 2006: Advance of Adenoviral Vector in Gene Therapy and Vaccine Research, Virologica Sinica, 21, 622-626.
[6]
Ke Zheng, Fang-Fang Jiang, Le Su, Xin Wang, Yu-Xin Chen, Huan-Chun Chen, Zheng-Fei Liu, 2020: Highly Efficient Base Editing in Viral Genome Based on Bacterial Artificial Chromosome Using a Cas9-Cytidine Deaminase Fused Protein, Virologica Sinica, 35, 191-199. doi: 10.1007/s12250-019-00175-4
[7]
Hubert E. Blum, 2008: Molecular Therapy and Prevention of Liver Diseases, Virologica Sinica, 23, 81-92. doi: 10.1007/s12250-008-2953-8
[8]
Hengrui Hu, Xiquan Ke, Han Xiao, Xianfei Shang, Qiran Yin, Jiang Li, Xiangmin Li, Zhihong Hu, Ping Qian, Manli Wang, 2026: Genomic assembly, rescue, and characterization of a functional pseudorabies virus, Virologica Sinica, 41, 97-106. doi: 10.1016/j.virs.2025.11.010
[9]
Nora Bahlmann, Montaha Alshawabkeh, Raphael Tsoukas, Katrin Schröer, Sebastian Schellhorn, Mareike Sieler, Thomas Dittmar, Eric Ehrke-Schulz, Anja Ehrhardt, Wenli Zhang, 2026: Desmoglein 2 (DSG2)-knockout human respiratory epithelial cell model to study species B adenovirus receptor usage, Virologica Sinica, 41, 172-181. doi: 10.1016/j.virs.2026.02.007
[10]
季伟, 王勤环, 斯崇文, 于敏, 张国庆, 刘丹, 1999: Inhibition of Hepatitis B Virus by Retroviral Vectors Expressing Antisenses PreS／S, Virologica Sinica, 14, 310-313.
[11]
张颖*, 白雪帆, 黄长形, 白宪光, 2004: HIV-1 Coreceptors and Coreceptor-related AIDS Therapy, Virologica Sinica, 19, 182-186.
[12]
刘子夜, 齐义鹏, 王业富, 1998: The virus vectors for gene therapy, Virologica Sinica, 13, 101-.
[13]
闰小君, 苏成芝, 吉昌华, 1993: Mutagenesis and Cloning of HIV-1 Protease Gene by Polymerase Chain Reaction, Virologica Sinica, 8, 154-.
[14]
Ling-bing ZENG, Lin-bai YE, Yuanan LU, 2007: Efficient Gene Transfer Mediated by HIV-1-based Defective Lentivector and Inhibition of HIV-1 Replication, Virologica Sinica, 22, 266-279.
[15]
王福祥, 孙永涛, 潘艳, 2005: SDF-1 Gene Modulates Immune Responses Induced by HIV-1 Nucleic Acid Vaccine, Virologica Sinica, 20, 243-246.
[16]
Xia FENG, Shuang-qing YU, Tsugumine Shu, Tetsuro Matano, Mamoru Hasegawa, Xiao-li WANG, Hong-tao MA, Hong-xia LI, Yi ZENG, 2008: Immunogenicity of DNA and Recombinant Sendai Virus Vaccines Expressing the HIV-1 gag Gene, Virologica Sinica, 23, 295-304. doi: 10.1007/s12250-008-2946-y
[17]
王福祥, 孙永涛, 刘娟, 马英骥, 杨宝山, 颜丙柱, 2005: Interleukin-12 Gene Modulates Immune Responses Induced by HIV-1 Nucleic Acid Vaccine, Virologica Sinica, 20, 16-19.
[18]
王福祥, 潘艳, 孙永涛, 2005: Chemokine Genes Modulate Immune Responses Induced by HIV-1 Envelope Protein Gene Vaccine, Virologica Sinica, 20, 578-581.
[19]
吉昌华, 苏成芝, 阎小君, 1992: Mutagenesis and Cloning of HIV-1 gag Gene Fragment by Polymerase Chain Reaction, Virologica Sinica, 7, 265-.
[20]
闭兰, 雷小军, 陈伟, 严家新, 余模松, 朱家鸿, 1998: High-level expression of HIV-1 gp41 gene and purification of its product, Virologica Sinica, 13, 344-.